EnvoyHealth to support Sun Pharma’s generic Gleevec patient program

FLINT, Mich. — Diplomat Pharmacy announced Monday that its HUB solution provider EnvoyHealth had been selected by Sun Pharma to support a patient assistance program for its generic Gleevec (imatinib mesylate). 

 

The call center will field questions patients may have about the treatment for adults and children with Philadelphia-positive chronic myeloid leukemia. It will also offer a 24/7 clinical helpline and offer an educational program and copay card enrollment. 

 

“Through EnvoyHealth working collaboratively with Sun Pharma, we have created a solution that puts patients first,” Diplomat CEO and chairman Phil Hagerman said. “This set of services will support patients with the education and services they need around imatinib mesylate use, to support them on their journey.”